We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$5.75B
AUM Growth
+$430M
Cap. Flow
-$1.1B
Cap. Flow %
-19.08%
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
378
Reduced
937
Closed
183

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$6.27M
2
TJX icon
TJX Companies
TJX
+$5.89M
3
GIS icon
General Mills
GIS
+$5.87M
4
HPQ icon
HP
HPQ
+$5.84M
5
F icon
Ford
F
+$5.38M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.7M
2
AMZN icon
Amazon
AMZN
+$14.9M
3
IRM icon
Iron Mountain
IRM
+$14.6M
4
MSFT icon
Microsoft
MSFT
+$12.9M
5
GDS icon
GDS Holdings
GDS
+$9.75M

Sector Composition

Rank Sector Weight
1 Real Estate 17.47%
2 Technology 14.6%
3 Consumer Discretionary 9.29%
4 Healthcare 7.36%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
1251
Sarepta Therapeutics
SRPT
$1.63B
$67K ﹤0.01%
895
+66
+8% +$6.09K
ALT icon
1252
Altimmune
ALT
$581M
$66K ﹤0.01%
+4,650
New +$75.2K
ATRA icon
1253
Atara Biotherapeutics
ATRA
$70.4M
$66K ﹤0.01%
184
+62
+51% +$27.4K
CCEP icon
1254
Coca-Cola Europacific Partners
CCEP
$49.2B
$66K ﹤0.01%
1,260
-501
-28% -$25.5K
GEL icon
1255
Genesis Energy
GEL
$1.81B
$66K ﹤0.01%
7,069
+704
+11% +$5.34K
IONS icon
1256
Ionis Pharmaceuticals
IONS
$9.14B
$66K ﹤0.01%
1,471
-1,410
-49% -$78.6K
TU icon
1257
Telus
TU
$16.7B
$66K ﹤0.01%
3,313
-175
-5% -$3.63K
ZNTL icon
1258
Zentalis Pharmaceuticals
ZNTL
$329M
$66K ﹤0.01%
1,530
+656
+75% +$28.2K
ARCT icon
1259
Arcturus Therapeutics
ARCT
$163M
$65K ﹤0.01%
1,578
+332
+27% +$19.8K
LKFT
1260
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$65K ﹤0.01%
838
-84
-9% -$7.74K
RGNX icon
1261
Regenxbio
RGNX
$615M
$65K ﹤0.01%
1,914
+180
+10% +$7.68K
BHVN
1262
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$65K ﹤0.01%
957
-548
-36% -$44.3K
GBIO
1263
DELISTED
Generation Bio
GBIO
$64K ﹤0.01%
224
+154
+220% +$49.3K
RCKT icon
1264
Rocket Pharmaceuticals
RCKT
$343M
$64K ﹤0.01%
1,447
+464
+47% +$25.5K
TPTX
1265
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$64K ﹤0.01%
678
-433
-39% -$51.5K
BCRX icon
1266
BioCryst Pharmaceuticals
BCRX
$2.48B
$63K ﹤0.01%
6,177
-9,768
-61% -$101K
BEAM icon
1267
Beam Therapeutics
BEAM
$2.7B
$63K ﹤0.01%
791
-742
-48% -$70.6K
PTCT icon
1268
PTC Therapeutics
PTCT
$6.25B
$63K ﹤0.01%
1,327
-704
-35% -$41.8K
TR icon
1269
Tootsie Roll Industries
TR
$2.94B
$63K ﹤0.01%
2,203
-14
-0.6% -$385
SRNE
1270
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$63K ﹤0.01%
7,606
-9,604
-56% -$101K
FMTX
1271
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$62K ﹤0.01%
2,213
+1,012
+84% +$36.5K
GLOB icon
1272
Globant
GLOB
$1.52B
$61K ﹤0.01%
292
-15
-5% -$3.19K
RYTM icon
1273
Rhythm Pharmaceuticals
RYTM
$7.41B
$61K ﹤0.01%
2,845
+1,462
+106% +$42.4K
KDMN
1274
DELISTED
Kadmon Holdings, Inc.
KDMN
$61K ﹤0.01%
15,587
+1,626
+12% +$7.45K
CNST
1275
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$61K ﹤0.01%
2,588
+276
+12% +$8.36K
49 50
51
52 53

Similar funds

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Pacer Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Pacer Advisors held 1,587 positions worth $5.75B, up 8.1% from $5.32B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pacer Advisors withdrew a net $1.1B in Q1 2021, closing 183 positions and reducing 937 holdings. Its most notable exit was Rithm Capital, an estimated $4.39M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pacer Advisors opened a new position in Aerojet Rocketdyne Holdings worth $3.39M.

  • Pacer Advisors's largest Q1 2021 buy was Aerojet Rocketdyne Holdings: 72,150 shares worth $3.39M.
  • Pacer Advisors added most to Newmont in Q1 2021, an estimated $6.27M increase.
  • Pacer Advisors's biggest Q1 2021 reduction was Apple, cutting an estimated $16.7M.
  • Pacer Advisors fully exited Rithm Capital in Q1 2021, selling an estimated $4.39M.
  • Pacer Advisors's ten largest holdings make up 27% of its $5.75B portfolio in Q1 2021.
  • Pacer Advisors opened 76 new positions and closed 183 in Q1 2021.
  • Pacer Advisors's portfolio value rose 8.1% quarter-over-quarter to $5.75B.

Based on Pacer Advisors's 13F filing for Q1 2021, filed 5 Apr 2021.